Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells
2003 · Cancer Science · 75 citations
https://doi.org/10.1111/j.1349-7006.2003.tb01482.x
X
Xiaofang Che
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
234
Papers
4.9K
Citations
41
h-index
126
i10-index
Xiaofang Che is an academic researcher from Qingdao University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Cancer-related molecular mechanisms research & RNA modifications and cancer. The author has an h-index of 41, co-authored 199 publications.
ORCID: 0000-0002-9087-1007Papers by this author
worksLncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma
2021 · Biomarker Research · 45 citations
https://doi.org/10.1186/s40364-021-00262-3
Bufalin induces protective autophagy by Cbl‐b regulating mTOR and ERK signaling pathways in gastric cancer cells
2018 · Cell Biology International · 31 citations
https://doi.org/10.1002/cbin.11076
Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B(NF-kB)-Dependent Pathway
2020 · Medical Science Monitor · 17 citations
https://doi.org/10.12659/msm.925019
Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells
2013 · Anti-Cancer Drugs · 15 citations
https://doi.org/10.1097/cad.0000000000000048
Sur-X, a novel peptide, kills colorectal cancer cells by targeting survivin-XIAP complex
2020 · Journal of Experimental & Clinical Cancer Research · 15 citations
https://doi.org/10.1186/s13046-020-01581-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat